The shortcomings of the RECIST study in HCC

Ghassan Abou-Alfa, MD, MBA, explains the shortcomings of the RECIST study in measuring efficacy in hepatocellular carcinoma (HCC) patients at ASCO 2018. Author: obr Added: 07/20/2018
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts